LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00066667
95.66 27.76 3364 6712 0.5011 0.8329
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
95.66 27.76 9823 6712 1.4634 1.0985
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
95.66 27.76 709 6712 0.1056 0.5057
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
95.66 27.76 7630 6712 1.1367 1.0326
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.001
1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
1.95 27.76 546 225 2.4251 1.6818
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
1.95 27.76 4 225 0.0178 -0.4735
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
1.95 27.76 611 225 2.7138 1.7836
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
3.66 27.76 1 283 0.0035 -0.6287
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
3.66 27.76 620 283 2.1836 1.5243
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
3.66 27.76 10 283 0.0352 -0.2624
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
3.66 27.76 698 283 2.4584 1.6151
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
5.36 27.76 701 320 2.1882 1.4969
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
5.36 27.76 16 320 0.0499 -0.1446
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
5.36 27.76 813 320 2.5378 1.6041
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
7.06 27.76 1 360 0.0028 -0.5930
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
7.06 27.76 798 360 2.2167 1.4805
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
7.06 27.76 19 360 0.0528 -0.0975
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
7.06 27.76 922 360 2.5611 1.5793
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
8.76 27.76 1 401 0.0025 -0.5779
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
8.76 27.76 874 401 2.1788 1.4480
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
8.76 27.76 30 401 0.0748 0.0204
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
8.76 27.76 1036 401 2.5826 1.5584
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
10.46 27.76 1 438 0.0023 -0.5660
MN20160318_Q01
H11